Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
---|---|---|---|---|---|
Revenue | -6.43% | -19.54% | -14.66% | 5.84% | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | -6.43% | -19.54% | -14.66% | 5.84% | |
Cost of Revenue | -6.24% | -20.89% | -17.42% | 5.68% | |
Gross Profit | -6.86% | -16.51% | -7.39% | 6.18% | |
SG&A Expenses | -7.61% | -16.06% | 64.59% | 4.96% | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -232.44% | -6,257.95% | 1,389.27% | 68.99% | |
Total Operating Expenses | -7.04% | -20.01% | -13.55% | 5.93% | |
Operating Income | 4.84% | -10.75% | -35.30% | 4.09% | |
Income Before Tax | 26.56% | -13.83% | -60.47% | -1.11% | |
Income Tax Expenses | 20.98% | -57.16% | 129.59% | 150.24% | |
Earnings from Continuing Operations | 29.37% | 30.53% | -242.21% | -24.18% | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | 29.37% | 30.53% | -242.21% | -24.18% | |
EBIT | 4.84% | -10.75% | -35.30% | 4.09% | |
EBITDA | -11.88% | -8.56% | -55.70% | 11.41% | |
EPS Basic | 29.17% | 31.33% | -241.98% | -23.81% | |
Normalized Basic EPS | 26.67% | -6.54% | -55.88% | -1.10% | |
EPS Diluted | 29.17% | 31.33% | -241.98% | -23.81% | |
Normalized Diluted EPS | 26.67% | -6.54% | -55.88% | -1.10% | |
Average Basic Shares Outstanding | 0.25% | 0.00% | 0.00% | -0.20% | |
Average Diluted Shares Outstanding | 0.25% | 0.00% | 0.00% | -0.20% | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | -- | -- | -- | -- |